Generic protocol for measuring COVID-19 vaccine effectiveness at primary care level in Europe - part of the I-MOVE-COVID-19 projectThis project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101003673
We measured COVID-19 vaccine effectiveness (VE) against symptomatic SARS-CoV-2 infection at primary ...
This project received funding from the European Centre for Disease Prevention and Control (ECDC) und...
Introduction: In July and August 2021, the SARS-CoV-2 Delta variant dominated in Europe. Aim: Using ...
Generic protocol for measuring COVID-19 vaccine effectiveness at primary care level in Europe - part...
This document presents the core I-MOVE-COVID-19 European protocol for measuring risk and protective ...
A generic protocol for COVID-19 surveillance at primary care level - from the I-MOVE-COVID-19 projec...
This document presents the core I-MOVE-COVID-19 European protocol for the 2020 hospital-based study ...
This surveillance report summarises the information from the I-MOVE-COVID-19 primary care surveillan...
This surveillance report summarises the information from the I-MOVE-COVID-19 primary care surveillan...
This document presents the core European protocol for the hospital-based surveillance component of I...
This document presents the core I-MOVE-COVID-19 European protocol for the hospital-based study of po...
This surveillance report summarises the information from the I-MOVE-COVID-19 hospital surveillance n...
This surveillance report summarises the information from the I-MOVE-COVID-19 hospital surveillance n...
We measured COVID-19 vaccine effectiveness (VE) against symptomatic SARS-CoV-2 infection at primary ...
We measured COVID-19 vaccine effectiveness (VE) against symptomatic SARS-CoV-2 infection at primary ...
We measured COVID-19 vaccine effectiveness (VE) against symptomatic SARS-CoV-2 infection at primary ...
This project received funding from the European Centre for Disease Prevention and Control (ECDC) und...
Introduction: In July and August 2021, the SARS-CoV-2 Delta variant dominated in Europe. Aim: Using ...
Generic protocol for measuring COVID-19 vaccine effectiveness at primary care level in Europe - part...
This document presents the core I-MOVE-COVID-19 European protocol for measuring risk and protective ...
A generic protocol for COVID-19 surveillance at primary care level - from the I-MOVE-COVID-19 projec...
This document presents the core I-MOVE-COVID-19 European protocol for the 2020 hospital-based study ...
This surveillance report summarises the information from the I-MOVE-COVID-19 primary care surveillan...
This surveillance report summarises the information from the I-MOVE-COVID-19 primary care surveillan...
This document presents the core European protocol for the hospital-based surveillance component of I...
This document presents the core I-MOVE-COVID-19 European protocol for the hospital-based study of po...
This surveillance report summarises the information from the I-MOVE-COVID-19 hospital surveillance n...
This surveillance report summarises the information from the I-MOVE-COVID-19 hospital surveillance n...
We measured COVID-19 vaccine effectiveness (VE) against symptomatic SARS-CoV-2 infection at primary ...
We measured COVID-19 vaccine effectiveness (VE) against symptomatic SARS-CoV-2 infection at primary ...
We measured COVID-19 vaccine effectiveness (VE) against symptomatic SARS-CoV-2 infection at primary ...
This project received funding from the European Centre for Disease Prevention and Control (ECDC) und...
Introduction: In July and August 2021, the SARS-CoV-2 Delta variant dominated in Europe. Aim: Using ...